35 studies found for:    "Chiari malformation type 2"
Show Display Options
RSS Create an RSS feed from your search for:
"Chiari malformation type 2"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Genetic Analysis of the Chiari I Malformation
Conditions: Syringomyelia;   Type I Arnold Chiari Malformation
Intervention:
2 Recruiting Study of the Safety and Effectiveness of Collagen Cross-Linking at an Irradiance of 9 mW/cm2 and 18 mW/cm2
Conditions: Keratoconus;   Corneal Ectasia
Interventions: Drug: Riboflavin 0.1% ophthalmic solution;   Device: CCL-VARIO UV lamp;   Device: CCL-VARIO at 18 mW/cm2
3 Recruiting Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2
Condition: Venous Leg Ulcers
Interventions: Biological: HP802-247;   Biological: Vehicle
4 Completed Compliance and Tolerability of Rivastigmine Transdermal Patch 10 cm² in Patients With Probable Alzheimer's Disease.
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine transdermal patch
5 Completed Safety and Toleration of PEP005 Topical Gel When Applied to a Treatment Area of up to 100cm2
Condition: Actinic Keratosis
Intervention: Drug: PEP005 Topical gel
6 Recruiting Safety and Efficacy of Escalating Doses of LEO 43204 Applied Once Daily for Two Consecutive Days on Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: LEO 43204;   Drug: Placebo
7 Completed Efficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Treatment Area of Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis
Condition: Actinic Keratosis
Intervention: Drug: ingenol mebutate
8 Recruiting NOVOCART®3D for Treatment of Articular Cartilage of the Knee
Condition: Articular Cartilage of the Femoral Condyle Between 2-6cm2
Interventions: Procedure: microfracture;   Biological: NOVOCART 3D
9 Enrolling by invitation Chiari Study Looking at Use of Duragen Versus Duraguard
Condition: Chiari Malformation Type I
Intervention:
10 Completed Establishing the Physiology of Syringomyelia
Conditions: Arnold Chiari Deformity;   Hydrocephalus;   Syringomyelia
Intervention:
11 Recruiting A Prospective Natural History Study of Patients With Syringomyelia
Conditions: Syringomyelia;   Arnold Chiari Deformity
Intervention:
12 Recruiting The Genetics of Chiari Type I Malformation
Condition: Chiari Type I Malformation
Intervention:
13 Recruiting Dural Graft Equivalent Comparison Trial
Condition: Chiari Malformation
Intervention: Procedure: decompression of Chiari malformation
14 Completed Duragen Versus Duraguard in Chiari Surgery
Condition: Chiari Malformation
Interventions: Procedure: Duraplasty with Duragen;   Procedure: Duraplasty with Duraguard
15 Active, not recruiting Magnetic Resonance Imaging (MRI) and Quantitative MR Cerebral Spinal Fluid (CSF) Flow Studies in Craniovertebral Junction Anomalies
Condition: Chiari Malformations
Intervention: Procedure: Dynamic cervical MRI
16 Completed
Has Results
Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis
Condition: Keratosis
Intervention: Drug: imiquimod cream
17 Completed
Has Results
Study in Healthy Volunteers to Prove That Two Different Formulations of Rotigotine Patches Deliver Equivalent Drug Amount to the Body
Condition: Healthy Volunteers
Intervention: Drug: Rotigotine transdermal patch
18 Completed
Has Results
A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-daily 10 cm^2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (EXTRA)
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine transdermal patch
19 Completed Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects
Condition: Healthy
Intervention: Drug: Rotigotine transdermal patch
20 Active, not recruiting A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis
Condition: Actinic Keratosis
Interventions: Drug: LEO 43204 Formulation 1;   Drug: LEO 43204 Formulation 2;   Drug: LEO 43204 Formulation 1 Dose X;   Drug: LEO 43204 Formulation 1 Dose Y;   Drug: LEO 43204 Formulation 2 Dose XX;   Drug: LEO 43204 Formulation 2 Dose YY;   Drug: Placebo Formulation 1;   Drug: Placebo Formulation 2

   Previous Page Studies Shown (1-20) Next Page (21-35) Show next page of results    Last Page
Indicates status has not been verified in more than two years